Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-06-16
1992-02-18
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
534 10, 534 14, A61K 4902, C07F 1300
Patent
active
050892495
ABSTRACT:
The present invention provides conjugates formed from calcified tissues targeting agents and radiolabeled compounds. One such conjugate comprises a chelate and a targeting agent that is capable of associating with calcified tissue, wherein the chelate contains at least one nitrogen atom or at least one sulfur atom or combinations thereof as the donor atoms.
Another aspect of the invention provides methods for using the conjugates for diagnostic and therapeutic purposes, including those related to bone cancer.
REFERENCES:
patent: 3852414 (1974-12-01), Adler et al.
patent: 3974268 (1976-08-01), Subramanian et al.
patent: 3987157 (1976-10-01), Molinski et al.
patent: 3989730 (1976-11-01), Subramanian et al.
patent: 4016249 (1977-04-01), Adler et al.
patent: 4017595 (1977-04-01), Subramanian et al.
patent: 4032625 (1977-06-01), Subramanian et al.
patent: 4082840 (1978-04-01), Adler et al.
patent: 4115541 (1978-09-01), Subramanian et al.
patent: 4233284 (1980-11-01), Fawzi
patent: 4247534 (1981-01-01), Bevan
patent: 4337240 (1982-06-01), Saklad
patent: 4439413 (1984-03-01), Hayashi et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4504462 (1985-03-01), Van Duzee et al.
patent: 4510125 (1985-04-01), Grogg et al.
patent: 4560548 (1985-12-01), Simon et al.
patent: 4582700 (1986-04-01), Dean et al.
patent: 4606907 (1986-08-01), Simon et al.
patent: 4617184 (1986-10-01), Tsolis et al.
patent: 4638051 (1987-01-01), Burns et al.
patent: 4642229 (1987-02-01), Cumming et al.
patent: 4666698 (1987-05-01), Schwarz
patent: 4810486 (1989-03-01), Kelly et al.
patent: 4830847 (1989-05-01), Benedict et al.
Reactivity and Structure Concepts in Organic Chemistry, vol. 21, titled The Practice of Peptide Synthesis, by M. Bodanszky, 1984.
.sup.131 I Labeled Diphosphonates for the Palliative Treatment of Bone Metastases-IV by Michael Eisenhut, Jill Barber, David Taylor, vol. 38, No. 7, pp. 535-540, 1987.
SM-EDTMP and RE-HEDP as Bone Therapeutic Radiopharmaceuticals, by Allan R. Ketring, Nucl. Med. Biol., vol. 14, No. 3, pp. 223-232, 1987.
Uptake of Technetium-99M Diphosphonate by Metastatic Large Cell Carcinoma of the Lung, J. Nucl. Med. 29:726-728 (1988).
Fitzner Jeffrey N.
Fritzberg Alan R.
Kasina Sudhakar
Vanderheyden Jean-Luc E.
Maples John S.
NeoRx Corporation
LandOfFree
Conjugates for bone imaging and bone cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugates for bone imaging and bone cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugates for bone imaging and bone cancer therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1821700